VolitionRx’s Nu.Q Cancer Test targets multi-billion-dollar liquid biopsy market

VolitionRx’s Nu.Q Cancer Test is transforming liquid biopsy diagnostics, offering a non-invasive, cost-effective blood test for early cancer detection. Read More